Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

A Marker for Breast Cancer

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
Research says it soon may be possible to gauge individual risk for disease, and eventually to treat it.

An international scientific collaborative led by the Harvard Stem Cell Institute’s Kornelia Polyak has discovered why women who give birth in their early 20s are less likely to develop breast cancer eventually than women who don’t, triggering a search for a way to confer this protective state on all women.

The researchers are now testing p27, a mammary gland progenitor marker, on tissue samples collected from thousands of women over decades — women whose medical histories have been followed extremely closely — to see if it is an accurate breast cancer predictor in a large population. If the hypothesis is confirmed, which appears likely within a few months, Polyak says the commercial development of a clinical test for breast cancer risk would follow.

In a paper just published in the journal Cell Stem Cell, the researchers describe how a full-term pregnancy when a woman is in her early 20s reduces the relative number and proliferative capacity of mammary gland progenitors — cells that have the ability to divide into milk-producing cells — making them less likely to acquire mutations that lead to cancer.

By comparing numerous breast tissue samples, the scientists found that women at high risk for breast cancer, such as those who inherit a mutated BRCA1 or BRCA2 gene, have higher-than-average numbers of mammary gland progenitors. In general, women who carried a child to full term had the lowest populations of mammary gland progenitors, even when compared with cancer-free women who had never been pregnant. In addition, in women who gave birth relatively early but later developed breast cancer, the number of mammary gland progenitors was again observed to be higher than average.

“The reason we are excited about this research is that we can use a progenitor cell census to determine who’s at particularly high risk for breast cancer,” said Polyak, a Harvard Stem Cell Institute principal faculty member and a Harvard Medical School professor at the Dana-Farber Cancer Institute. “We could use this strategy to decrease cancer risk because we know what regulates the proliferation of these cells, and we could deplete them from the breast.”

Research shows that two trends are contributing to an increase in the number of breast cancer diagnoses, a rise in obesity and the ever-increasing number of women postponing childbearing. The scientists’ long-range goal is to develop a treatment that would mimic the protective effects of early childbearing.

The research, which took five years to complete, began with conversations between Polyak and Saraswati Sukumar, a professor at Johns Hopkins University School of Medicine. The two scientists formed collaborations with clinicians at cancer centers that see large numbers of high-risk women, in order to obtain breast tissue samples. They also worked with genomics experts and bioinformaticians to analyze gene expression in different breast cell types. At times, Polyak and Sukumar had trouble gaining cooperation for the study, which is unique in the breast cancer field for its focus on risk prediction and prevention.

“In general, people who study cancer always want to focus on treating the cancer. But, in reality, preventing cancer can have the biggest impact on cancer-associated morbidity and mortality,” Polyak said. “I think the mentality has to change because breast cancer affects so many women, and even though many of them are not dying of breast cancer, there’s a significant personal and societal burden.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Tuesday, November 24, 2015
On Top of the Flu
Chance for advance warning in search-based tracking method.
Thursday, November 12, 2015
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
Monday, October 05, 2015
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Thursday, October 01, 2015
Exposure to Pesticides In Childhood Linked to Cancer
Young children who are exposed to insecticides inside their homes may be slightly more at risk for developing leukemia or lymphoma during childhood, according to a meta-analysis by Harvard T.H. Chan School of Public Health researchers.
Thursday, September 24, 2015
Genetic Sleuthing
Sabeti team applies Ebola methods to shed light on spread of Lassa fever.
Thursday, September 17, 2015
Why MS Symptoms May Improve As Days Get Shorter
New research from Brigham and Women’s Hospital offers an answer to ‘seasonal paradox’.
Monday, September 14, 2015
So Long, Snout
Research helps answer how birds got their beaks.
Thursday, August 20, 2015
Asthma Cells Scramble Like ‘There’s a Fire Drill’
Movement offers insight into mechanisms of asthma, other diseases.
Friday, August 14, 2015
Delivering Hope in Ovarian Cancer
Gene therapy blocked chemoresistant tumor growth in mice.
Tuesday, August 11, 2015
Potential Treatment for Muscular Dystrophy
A new method for producing muscle cells could offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options.
Wednesday, August 05, 2015
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Friday, July 31, 2015
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
Monday, July 27, 2015
Pesticide Found in 70 Percent of Massachusetts’ Honey Samples
New Harvard University study says that the pesticide commonly found in honey samples is implicated in Colony Collapse Disorder.
Monday, July 27, 2015
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
Tuesday, June 23, 2015
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos